Onconova Therapeutics, Inc. Warrants
ONTXW
ONTXW was delisted on the 23rd of July, 2021.
3 hedge funds and large institutions have $17K invested in Onconova Therapeutics, Inc. Warrants in 2019 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
35% less capital invested
Capital invested by funds: $26K → $17K (-$9K)
40% less funds holding
Funds holding: 5 → 3 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$764 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$13K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$3K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.08K |
ONTXW Hedge Fund Activity: Q4 2019 in Review
3 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Onconova Therapeutics, Inc. Warrants (ONTXW) for Q4 2019, worth a combined $17K — down 35% from $26K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ONTXW and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $764. The largest seller was Sabby Management, exiting entirely with an estimated $13K sold.
- 3 institutional investors held Onconova Therapeutics, Inc. Warrants (ONTXW) as of Q4 2019, down from 5 in Q3 2019.
- Funds reported $17K of Onconova Therapeutics, Inc. Warrants stock for Q4 2019, down 35% quarter-over-quarter.
- 0 funds opened new Onconova Therapeutics, Inc. Warrants positions in Q4 2019 and 2 closed out, a net change of -2 holders.
- The largest Onconova Therapeutics, Inc. Warrants buyer in Q4 2019 was UBS Group, an estimated $764 added.
- The largest Onconova Therapeutics, Inc. Warrants seller in Q4 2019 was Sabby Management, an estimated $13K sold.
Based on aggregated 13F filings for Q4 2019.